Propanc Biopharma, INC 8-K filings

Propanc Biopharma, Inc. has updated its corporate overview and company presentation, making the updated materials available to the public.

Propanc Biopharma, Inc. has entered into a securities purchase agreement for a $50,000 convertible promissory note to enhance its working capital.